Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Remedy Taking a hit why? -- Ignore unavailable to you. Want to Upgrade?

To: hari t who wrote (638)	1/23/1999 8:46:00 AM
From: Joe Dancy	Read Replies (1) \| Respond to of 763

Mark Johnson of SI's IFC site did an interview with Michael Murphy of the Cal Tech Letter a few weeks ago - one of the companies Murphy liked was RMDY. FWIW, you can hear Mark's interview at audioinvestor.com Joe

To: hari t who wrote (638)	1/25/1999 4:55:00 PM
From: anthony bui	Read Replies (1) \| Respond to of 763

RMDY earns 26c/Shr. MOUNTAIN VIEW, Calif., Jan. 25 /PRNewswire/ -- Remedy® Corporation (Nasdaq: RMDY - news), the leading provider of adaptable enterprise applications, today announced results for the fourth fiscal quarter ended December 31, 1998. Revenues for the fourth quarter totaled $50.1 million, an increase of 29% compared with $38.8 million in the fourth quarter of 1997. Operating profit prior to acquisition related charges totaled $10.1 million, or 20% of revenue, in the fourth quarter of 1998. Net income and diluted earnings per share were $7.6 million and $0.26, respectively, excluding non-recurring charges related to the acquisition of BayStone® Software. Net income and diluted earnings per share for the fourth quarter, including acquisition-related charges, were $5.6 million and $0.19, respectively. For the twelve months ended December 31, 1998, revenue increased 22% to $157.4 million from $129.2 million for fiscal 1997. Fiscal 1998 net income totaled $21.0 million or $0.70 per share excluding acquisition-related charges. Net income including acquisition-related charges was $19.0 million or $0.63 per share. ''We are pleased with our performance this quarter, especially the progress we've made in strengthening our sales organization and in expanding our product portfolio,'' commented Larry Garlick, Chairman and Chief Executive Officer. ''We look forward to the year ahead, as we move into strong product introduction cycles targeting our three strategic markets and our core platform customers.'' Remedy provides web and client/server solutions for IT Service Management, Customer Relationship Management, and Employee Productivity.